Data for two hypothetical companies in the pharmaceutical industry, DriveMed and MAT Technology, are given in the following table. For both companies, expenditures on fixed capital and working capital during the previous year reflect anticipated average expenditures over the foreseeable horizon.

Measure		DriveMed		MAT Technology
Current price		$47.00		$77.00
Trailing CF per share		$3.60		$6.00
P/CF		13.1		12.8
Trailing FCFE per share		$3.00		$2.00
P/FCFE		15.7		38.5
Consensus five - year growth forecast		15%		20%
Beta		1.25		1.25

Based on the information supplied, discuss the valuation of MAT Technology relative to DriveMed.Fullyexplain and justify your conclusion.